543064 Stock Overview
Operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 543064 from our risk checks.
Suven Pharmaceuticals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,325.35 |
| 52 Week High | ₹1,358.75 |
| 52 Week Low | ₹542.35 |
| Beta | 1.39 |
| 11 Month Change | 14.36% |
| 3 Month Change | 33.77% |
| 1 Year Change | 131.66% |
| 33 Year Change | 158.43% |
| 5 Year Change | n/a |
| Change since IPO | 688.90% |
Recent News & Updates
Recent updates
Shareholder Returns
| 543064 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 4.0% | 3.0% | 1.6% |
| 1Y | 131.7% | 54.1% | 36.9% |
Return vs Industry: 543064 exceeded the Indian Pharmaceuticals industry which returned 54.6% over the past year.
Return vs Market: 543064 exceeded the Indian Market which returned 35.3% over the past year.
Price Volatility
| 543064 volatility | |
|---|---|
| 543064 Average Weekly Movement | 4.5% |
| Pharmaceuticals Industry Average Movement | 6.3% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.3% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 543064 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 543064's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | n/a | Sudhir Singh | suvenpharm.com |
Suven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally. It develops, manufactures, and sells new chemical entity-based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies. The company was founded in 1989 and is based in Hyderabad, India.
Suven Pharmaceuticals Limited Fundamentals Summary
| 543064 fundamental statistics | |
|---|---|
| Market cap | ₹337.03b |
| Earnings (TTM) | ₹2.40b |
| Revenue (TTM) | ₹9.34b |
140.2x
P/E Ratio36.1x
P/S RatioIs 543064 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 543064 income statement (TTM) | |
|---|---|
| Revenue | ₹9.34b |
| Cost of Revenue | ₹4.07b |
| Gross Profit | ₹5.27b |
| Other Expenses | ₹2.87b |
| Earnings | ₹2.40b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 9.45 |
| Gross Margin | 56.41% |
| Net Profit Margin | 25.73% |
| Debt/Equity Ratio | 3.2% |
How did 543064 perform over the long term?
See historical performance and comparison